Report Detail
Global Heart Failure Therapeutics Market Research Report 2019
- RnM2728604 |
- 06 February, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
The global Heart Failure Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Heart Failure Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Failure Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Segment by Application
Hospital
Clinic
Medical Research Organization
Table of Contents
Executive Summary
1 Heart Failure Therapeutics Market Overview
- 1.1 Product Overview and Scope of Heart Failure Therapeutics
- 1.2 Heart Failure Therapeutics Segment by Type
- 1.2.1 Global Heart Failure Therapeutics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Diagnosis
- 1.2.3 Prognosis
- 1.2.4 Treatment Options and Treatment Algorithm
- 1.3 Heart Failure Therapeutics Segment by Application
- 1.3.1 Heart Failure Therapeutics Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Medical Research Organization
- 1.3 Global Heart Failure Therapeutics Market by Region
- 1.3.1 Global Heart Failure Therapeutics Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Heart Failure Therapeutics Market Size
- 1.4.1 Global Heart Failure Therapeutics Revenue (2014-2025)
- 1.4.2 Global Heart Failure Therapeutics Production (2014-2025)
2 Global Heart Failure Therapeutics Market Competition by Manufacturers
- 2.1 Global Heart Failure Therapeutics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Heart Failure Therapeutics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Heart Failure Therapeutics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Heart Failure Therapeutics Production Sites, Area Served, Product Types
- 2.5 Heart Failure Therapeutics Market Competitive Situation and Trends
- 2.5.1 Heart Failure Therapeutics Market Concentration Rate
- 2.5.2 Heart Failure Therapeutics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Heart Failure Therapeutics Production Market Share by Regions
- 3.1 Global Heart Failure Therapeutics Production Market Share by Regions
- 3.2 Global Heart Failure Therapeutics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Heart Failure Therapeutics Production
- 3.4.1 North America Heart Failure Therapeutics Production Growth Rate (2014-2019)
- 3.4.2 North America Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Heart Failure Therapeutics Production
- 3.5.1 Europe Heart Failure Therapeutics Production Growth Rate (2014-2019)
- 3.5.2 Europe Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Heart Failure Therapeutics Production (2014-2019)
- 3.6.1 China Heart Failure Therapeutics Production Growth Rate (2014-2019)
- 3.6.2 China Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Heart Failure Therapeutics Production (2014-2019)
- 3.7.1 Japan Heart Failure Therapeutics Production Growth Rate (2014-2019)
- 3.7.2 Japan Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Heart Failure Therapeutics Consumption by Regions
- 4.1 Global Heart Failure Therapeutics Consumption by Regions
- 4.2 North America Heart Failure Therapeutics Consumption (2014-2019)
- 4.3 Europe Heart Failure Therapeutics Consumption (2014-2019)
- 4.4 China Heart Failure Therapeutics Consumption (2014-2019)
- 4.5 Japan Heart Failure Therapeutics Consumption (2014-2019)
5 Global Heart Failure Therapeutics Production, Revenue, Price Trend by Type
- 5.1 Global Heart Failure Therapeutics Production Market Share by Type (2014-2019)
- 5.2 Global Heart Failure Therapeutics Revenue Market Share by Type (2014-2019)
- 5.3 Global Heart Failure Therapeutics Price by Type (2014-2019)
- 5.4 Global Heart Failure Therapeutics Production Growth by Type (2014-2019)
6 Global Heart Failure Therapeutics Market Analysis by Applications
- 6.1 Global Heart Failure Therapeutics Consumption Market Share by Application (2014-2019)
- 6.2 Global Heart Failure Therapeutics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Heart Failure Therapeutics Business
- 7.1 Bayer
- 7.1.1 Bayer Heart Failure Therapeutics Production Sites and Area Served
- 7.1.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.1.3 Bayer Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Cynokinetics
- 7.2.1 Cynokinetics Heart Failure Therapeutics Production Sites and Area Served
- 7.2.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.2.3 Cynokinetics Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Les Laboratoires Servier
- 7.3.1 Les Laboratoires Servier Heart Failure Therapeutics Production Sites and Area Served
- 7.3.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.3.3 Les Laboratoires Servier Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Merck & Co.
- 7.4.1 Merck & Co. Heart Failure Therapeutics Production Sites and Area Served
- 7.4.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.4.3 Merck & Co. Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Novartis
- 7.5.1 Novartis Heart Failure Therapeutics Production Sites and Area Served
- 7.5.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.5.3 Novartis Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Procoralan
- 7.6.1 Procoralan Heart Failure Therapeutics Production Sites and Area Served
- 7.6.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.6.3 Procoralan Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Bristol-Myers Squibb Company
- 7.7.1 Bristol-Myers Squibb Company Heart Failure Therapeutics Production Sites and Area Served
- 7.7.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Cardiorentis AG
- 7.8.1 Cardiorentis AG Heart Failure Therapeutics Production Sites and Area Served
- 7.8.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.8.3 Cardiorentis AG Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 CVie Therapeutics Limited
- 7.9.1 CVie Therapeutics Limited Heart Failure Therapeutics Production Sites and Area Served
- 7.9.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Orion Corporation
- 7.10.1 Orion Corporation Heart Failure Therapeutics Production Sites and Area Served
- 7.10.2 Heart Failure Therapeutics Product Introduction, Application and Specification
- 7.10.3 Orion Corporation Heart Failure Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 PhaseBio Pharmaceuticals
- 7.12 Market Segment by Product Type
- 7.13 B-Blockers
- 7.14 Calcium Channel Blockers
- 7.15 Cardiac Glycosides
- 7.16 Diuretics
- 7.17 Morphine
- 7.18 Vasodilators/Nitrates
8 Heart Failure Therapeutics Manufacturing Cost Analysis
- 8.1 Heart Failure Therapeutics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Heart Failure Therapeutics
- 8.4 Heart Failure Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Heart Failure Therapeutics Distributors List
- 9.3 Heart Failure Therapeutics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Heart Failure Therapeutics Market Forecast
- 11.1 Global Heart Failure Therapeutics Production, Revenue Forecast
- 11.1.1 Global Heart Failure Therapeutics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Heart Failure Therapeutics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Heart Failure Therapeutics Price and Trend Forecast (2019-2025)
- 11.2 Global Heart Failure Therapeutics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Heart Failure Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Heart Failure Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Heart Failure Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Heart Failure Therapeutics Production, Revenue Forecast (2019-2025)
- 11.3 Global Heart Failure Therapeutics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Heart Failure Therapeutics Consumption Forecast (2019-2025)
- 11.3.2 Europe Heart Failure Therapeutics Consumption Forecast (2019-2025)
- 11.3.3 China Heart Failure Therapeutics Consumption Forecast (2019-2025)
- 11.3.4 Japan Heart Failure Therapeutics Consumption Forecast (2019-2025)
- 11.4 Global Heart Failure Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Heart Failure Therapeutics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Heart Failure Therapeutics. Industry analysis & Market Report on Heart Failure Therapeutics is a syndicated market report, published as Global Heart Failure Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Heart Failure Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
